Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
BioMarin to Buy Amicus Therapeutics for $4.8 Billion
08:13am, Friday, 19'th Dec 2025
BioMarin Pharmaceutical has struck a deal to buy fellow biotechnology company Amicus Therapeutics for about $4.8 billion in cash.
BioMarin to acquire Amicus Therapeutics for $4.8 Billion
07:56am, Friday, 19'th Dec 2025
BioMarin Pharmaceutical said on Friday it will acquire Amicus Therapeutics in an all-cash deal worth about $4.8 billion.
BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with $599 Mi
AQR Capital Management LLC Acquires 2,654,768 Shares of BioMarin Pharmaceutical Inc. $BMRN
04:58am, Saturday, 13'th Dec 2025
AQR Capital Management LLC boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 90.7% during the undefined quarter, according to its most recent 13F filing with the SEC. The f
Critical Survey: BioMarin Pharmaceutical (NASDAQ:BMRN) & Contineum Therapeutics (NASDAQ:CTNM)
02:26am, Sunday, 30'th Nov 2025
BioMarin Pharmaceutical (NASDAQ: BMRN - Get Free Report) and Contineum Therapeutics (NASDAQ: CTNM - Get Free Report) are both medical companies, but which is the superior stock? We will compare the tw
BioMarin Pharmaceutical Inc. (BMRN) Presents at Jefferies London Healthcare Conference 2025 Transcript
09:08am, Tuesday, 18'th Nov 2025
BioMarin Pharmaceutical Inc. ( BMRN ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants Alexander Hardy - President, CEO & Director Brian Mueller - Executi
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Envestnet Asset Management Inc.
04:34am, Monday, 17'th Nov 2025
Envestnet Asset Management Inc. lifted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 15.4% during the second quarter, according to the company in its most recent Form 13F fi
Alberta Investment Management Corp Invests $4.02 Million in BioMarin Pharmaceutical Inc. $BMRN
03:30am, Monday, 17'th Nov 2025
Alberta Investment Management Corp acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) in the undefined quarter, according to its most recent disclosure with the Securities a
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Acadian Asset Management LLC
03:15am, Friday, 14'th Nov 2025
Acadian Asset Management LLC grew its position in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 285.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securi
SAN RAFAEL, Calif. , Nov. 11, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday, No
D.A. Davidson & CO. Raises Holdings in BioMarin Pharmaceutical Inc. $BMRN
05:26am, Friday, 31'st Oct 2025
D.A. Davidson and CO. grew its position in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 4.9% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commis
Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet alone FDA PDUFA target action date of
Asset Management One Co. Ltd. Has $4.84 Million Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN
03:38am, Wednesday, 29'th Oct 2025
Asset Management One Co. Ltd. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 8.8% during the second quarter, according to the company in its most recent 13F filing with the Secu
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
04:59pm, Tuesday, 28'th Oct 2025
The biotech published its latest set of quarterly results. It posted a surprise net profit for the period.
BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy
03:31pm, Tuesday, 28'th Oct 2025
BMRN tops Q3 earnings expectations but misses on sales. The company moves to divest its hemophilia gene therapy, Roctavian.
